Gonadorelin vs HCG
Head-to-head comparison of Gonadorelin and HCG for research applications. Both peptides are studied for Reproductive Health, but they differ significantly in mechanism, evidence level, and dosing protocols.
Side-by-Side Comparison
| Attribute | Gonadorelin | Hcg |
|---|---|---|
| Category | Reproductive / Hormonal | Hormonal / Reproductive |
| Mechanism | Gonadorelin binds to GnRH receptors on gonadotrope cells in the anterior pituitary gland, stimulating release of LH and FSH. | HCG binds to the LH/CG receptor (LHCGR) on Leydig cells and theca cells with high affinity. In males, this stimulates intratesticular testosterone production, spermatogenesis, and maintains testicular volume. |
| Evidence Rating | A — FDA Approved | A — FDA Approved |
| Clinical Status | FDA-approved (Factrel for diagnostic use; Lutrepulse for pulsatile infertility treatment, now discontinued). Generic diagnostic formulation available. | FDA-approved for anovulation/infertility, hypogonadotropic hypogonadism, prepubertal cryptorchidism. |
| Safety Profile | Common: headache, flushing, nausea, dizziness, injection site reactions; Rare: facial/lip/tongue/throat swelling (allergic reaction) | Common: injection site reactions, headache, fatigue, mood changes; Males: gynecomastia (from estradiol conversion), water retention, testicular discomfort |
| Route | Subcutaneous or Intravenous | Subcutaneous injection |
| Dose Range | Diagnostic: 100 mcg IV/SC single dose; TRT support: 50–100 mcg SC 2x daily | 250-500 IU per injection (750-1500 IU/week) |
| Frequency | Diagnostic: single dose; TRT support: 2x daily or pulsatile | 3 times per week |
| Molecular Weight | ~1182.4 g/mol | ~36,700 g/mol (glycoprotein) |
| Half-Life | ~2–4 minutes IV; ~40 minutes SC | ~24-36 hours |
Overview
Gonadorelin and HCG are both research peptides studied across multiple applications. This comparison examines their mechanisms, evidence base, dosing protocols, and safety profiles to help researchers understand the key differences and overlaps.
Gonadorelin — Mechanism & Evidence
Gonadorelin is a synthetic decapeptide identical to the naturally occurring gonadotropin-releasing hormone (GnRH) produced in the hypothalamus. It stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which regulate testosterone production in men and ovulation in women. It is used clinically for diagnostic testing of pituitary function, and in pulsatile administration for certain infertility conditions. In the peptide community, it is commonly discussed as a complement to testosterone replacement therapy to maintain testicular function and fertility.
Key claims: Maintains testicular function during TRT; Restores fertility in hypothalamic amenorrhea; Diagnostic test for pituitary function.
BPC-157 5mg
5mg
Retatrutide 20mg
20mg
HCG — Mechanism & Evidence
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone (MW ~36,700 g/mol) composed of an alpha subunit (shared with LH, FSH, TSH) and a unique beta subunit. Naturally produced by placental trophoblasts during pregnancy, pharmaceutical HCG binds LH/CG receptors in the gonads, stimulating testosterone production in Leydig cells and progesterone in the corpus luteum. It is FDA-approved for multiple reproductive indications and is widely used off-label to maintain testicular function during testosterone replacement therapy (TRT).
Key claims: Maintains testicular function during TRT; Preserves fertility during testosterone use; Triggers ovulation in fertility treatment.
Shared Research Applications
Both peptides are studied for: Reproductive Health.
Gonadorelin is also researched for: no additional unique applications.
HCG is also researched for: Hormonal.
Safety Considerations
Gonadorelin: Common: headache, flushing, nausea, dizziness, injection site reactions Rare: facial/lip/tongue/throat swelling (allergic reaction) Injection site hardening with repeated SC administration
HCG: Common: injection site reactions, headache, fatigue, mood changes Males: gynecomastia (from estradiol conversion), water retention, testicular discomfort Females: ovarian hyperstimulation syndrome (OHSS) — potentially serious
Shop Research Peptides
BPC-157 5mg
5mg
Retatrutide 20mg
20mg
Retatrutide 10mg
10mg
GHK-Cu 50mg
50mg
Tesamorelin 10mg
10mg
BPC-157 10mg
10mg
Tirzepatide 10mg
10mg
KPV 10mg
10mg
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
Peptide Tools
Follow Research Updates
Get new research pages, product updates, tool releases, and quality resources from Volta.
Subscribe